EPAS1 and paraganglioma: Many patients with tumours located in the adrenal gland (phaeochromocytomas) showed EPAS1 DNA amplification when compared to those with tumours outside adrenal gland (paragangliomas) (84.21% versus 57.14%; p = 0.037).